The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
Recruiting
N/A
Interventional Study
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 55 – 69
- Sex
- Male
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 5,000 (estimated)
- Sponsor
- VA Office of Research and Development · Federal
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prostate cancer is the most common non-skin cancer among Veterans and the second leading cause of male cancer death. Current methods of screening men for prostate cancer are inaccurate and cannot identify which men do not have prostate cancer or have low-grade cases that will not cause harm and which men have significant prostate cancer needing treatment. False-positive screening tests can result …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* baseline age 55-69 years
* receipt of regular VA care
* Veteran status
Exclusion Criteria:
* personal history of prostate cancer
* prior prostate biopsy, prostatectomy, or prostate MRI
* known carrier status of rare variant associated with cancer syndrome
Contacts